Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-28

Clinical Trial Update: Post Market Study of the InnFocus MicroShunt [NA]

View source ↗

Summary

Post-market clinical trial update for the InnFocus MicroShunt in primary open-angle glaucoma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InnFocus MicroShunt

Snippet

Sponsor: InnFocus Inc. | Conditions: Primary Open Angle Glaucoma | NA | Status: COMPLETED | Results posted: 2021-05-28